S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NYSE:DPLO

Diplomat Pharmacy Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$4.00
0.00 (0.00%)
(As of 02/7/2020)
Add
Compare
Today's Range
$4.00
$4.01
50-Day Range
$4.00
$4.00
52-Week Range
$2.43
$14.46
Volume
744,968 shs
Average Volume
545,194 shs
Market Capitalization
$304 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.82

Receive DPLO News and Ratings via Email

Sign-up to receive the latest news and ratings for Diplomat Pharmacy and its competitors with MarketBeat's FREE daily newsletter.


Diplomat Pharmacy logo

About Diplomat Pharmacy

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company operates through Specialty and PBM (pharmacy benefit management) segment. It provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems. The company primarily focuses on medication management programs for individuals with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy, and various other serious or long-term conditions. It also offers PBM services, including electronic point-of-sale pharmacy claims management, retail pharmacy network management, mail pharmacy claims management, specialty pharmacy claims management, Medicare Part D services, benefit design consultation, drug review and analysis, consulting services, data access, and reporting, information analysis, and preferred drug management programs to managed care organizations, self-insured employer groups, unions, and third-party healthcare plan administrators and worker's compensation payers. The company was founded in 1975 and is headquartered in Flint, Michigan.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
N/A
Fax
N/A
Employees
2,335
Year Founded
N/A

Sales & Book Value

Annual Sales
$5.49 billion
Cash Flow
$4.60 per share
Book Value
$6.24 per share

Profitability

Net Income
$-302.27 million
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$304 million
Optionable
Optionable

Company Calendar

Last Earnings
11/12/2019
Today
11/27/2021

MarketRank

Overall MarketRank

1.80 out of 5 stars

Retail/Wholesale Sector

180th out of 274 stocks

Drug Stores & Proprietary Stores Industry

5th out of 10 stocks

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 1.3 5 -4 -3 -2 -1 -












Diplomat Pharmacy (NYSE:DPLO) Frequently Asked Questions

How were Diplomat Pharmacy's earnings last quarter?

Diplomat Pharmacy Inc (NYSE:DPLO) issued its quarterly earnings data on Tuesday, November, 12th. The company reported ($2.35) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by $2.15. The company had revenue of $1.30 billion for the quarter, compared to the consensus estimate of $1.17 billion. Diplomat Pharmacy had a negative trailing twelve-month return on equity of 12.15% and a negative net margin of 12.47%. Diplomat Pharmacy's quarterly revenue was down 5.3% on a year-over-year basis.
View Diplomat Pharmacy's earnings history
.

Who are Diplomat Pharmacy's key executives?

Diplomat Pharmacy's management team includes the following people:
  • Mr. Brian Thomas Griffin, CEO & Chairman (Age 60)
  • Mr. Philip R. Hagerman, Co-Founder & Chairman Emeritus (Age 67)
  • Mr. Daniel Paul Davison, CFO & Treasurer
  • Mr. Dave Loschinskey, Chief Operating Officer (Age 48)
  • Ms. Terri Anne Powers, VP of Investor Relations

What other stocks do shareholders of Diplomat Pharmacy own?

What is Diplomat Pharmacy's stock symbol?

Diplomat Pharmacy trades on the New York Stock Exchange (NYSE) under the ticker symbol "DPLO."

What is Diplomat Pharmacy's stock price today?

One share of DPLO stock can currently be purchased for approximately $4.00.

How much money does Diplomat Pharmacy make?

Diplomat Pharmacy has a market capitalization of $304 million and generates $5.49 billion in revenue each year. The company earns $-302.27 million in net income (profit) each year or $0.20 on an earnings per share basis.

How many employees does Diplomat Pharmacy have?

Diplomat Pharmacy employs 2,335 workers across the globe.

What is Diplomat Pharmacy's official website?

The official website for Diplomat Pharmacy is www.diplomatpharmacy.com.

Where are Diplomat Pharmacy's headquarters?

Diplomat Pharmacy is headquartered at 4100 S. SAGINAW ST., FLINT MI, 48507.

How can I contact Diplomat Pharmacy?

Diplomat Pharmacy's mailing address is 4100 S. SAGINAW ST., FLINT MI, 48507. The company can be reached via phone at 888-720-4450 or via email at [email protected].


This page was last updated on 11/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.